查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1954510

日本家用診斷檢測市場規模、佔有率、趨勢及預測（按檢測類型、形式、通路和地區分類，2026-2034年）

Japan Home Diagnostic Testing Market Size, Share, Trends and Forecast by Test Type, Form, Distribution Channel, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

預計到 2025 年，日本家庭診斷測試市場規模將達到 3.5556 億美元，到 2034 年將達到 9.5629 億美元，2026 年至 2034 年的複合年成長率為 11.62%。

受人口老化加劇導致慢性病發病率上升以及消費者對頻繁健康監測需求不斷成長的推動，日本家用診斷檢測市場持續穩定擴張。意識提升以及對便利家庭檢測方案的偏好進一步強化了這項需求。政府推行的預防醫學和數位健康融合政策也促進了市場成長。攜帶式診斷設備的科技進步、零售藥局網路的擴張以及電子商務滲透率的提高，提升了產品在全國範圍內的可及性，從而推動了日本家用診斷檢測市場佔有率的成長。

主要結論與見解：

  • 按測試類型分類：到 2025 年，血糖值監測儀將以 34% 的市場佔有率引領市場，這主要得益於需要定期進行血糖值管理的糖尿病患者人數不斷增加，以及老年人群體對持續血糖監測系統日益成長的需求，他們正在尋求便捷的疾病管理解決方案。
  • 按形式分類：到 2025 年，試紙將以 29% 的市場佔有率引領市場，這得益於其成本效益、易於用於自我測試以及在全國零售藥局和藥房的廣泛供應。
  • 按分銷管道分類：到 2025 年，零售藥局將成為最大的細分市場，佔市場佔有率的 40%。這主要得益於消費者對藥劑師指導的信任、廣泛的門市網路提供全面的產品種類，以及能夠即時獲得醫療需求產品的便利性。
  • 從地區來看，到 2025 年，關東地區將以 36% 的市佔率領先。這主要歸功於大東京地區人口稠密、醫療基礎設施先進、消費者購買力強，以及大型醫療機構和數位健康Start-Ups的存在。
  • 主要參與者：日本家用診斷測試市場呈現競爭適中的格局，成熟的跨國診斷公司與國內製造商並存，提供涵蓋各種測試類別和價格點的多樣化產品系列。

日本家庭診斷檢測市場持續受益於國家對醫療創新的大力投入以及科技與日常健康管理的無縫整合。厚生勞動省第八次醫療策略計畫（2024-2029）強調資訊通訊技術（ICT）數位化在醫療保健領域的應用，為家庭診斷解決方案創造了有利環境。消費者日益重視隱私，尤其是在敏感疾病的健康檢查方面，這進一步推動了對無需就醫即可獲得準確結果的家庭檢測替代方案的需求。零售通路的拓展、預防性檢測保險覆蓋範圍的擴大以及政府大力推廣早期檢測，也增強了市場前景。隨著製造商推出更多便捷可靠的疾病特異性檢測套組，預計將實現市場多元化和加速成長，從而吸引尋求獨立生活的老年人和希望更快、更便捷地獲取健康資訊的年輕人。

日本家用診斷檢測市場的發展趨勢：

人工智慧 (AI) 與數位健康技術的融合

隨著人工智慧（AI）技術融入診斷設備和健康平台，日本的家用診斷市場正經歷重大變革。配備機器學習（ML）演算法的智慧診斷設備能夠實現持續的健康監測和潛在疾病的早期檢測。這些技巧有助於及時干預，同時減少患者頻繁就醫的次數。 2025年1月，Monitor公司與DoctorNet合作，在日本推出了人工智慧肺癌診斷工具“MONCAD CTLN”，這體現了日本致力於透過人工智慧提升診斷能力的決心。

遠端醫療和遠端患者監護的興起

遠端醫療服務的擴展與日本各地的居家診斷檢測解決方案形成了協同效應。數位健康平台正加強與居家檢測套組的整合，從而實現患者與醫療服務提供者之間無縫的數據共用。這一趨勢反映了消費者對便利醫療服務日益成長的需求，並有助於緩解醫療機構的擁擠狀況。 2024年7月，亞馬遜在日本推出了藥房服務，與多家當地藥房合作，將處方藥直接送到客戶家中，並透過數位應用程式提供藥劑師諮詢服務。

即時檢測 (POC) 解決方案的採用率不斷提高

隨著消費者和醫療機構對在傳統檢查室之外獲得即時診斷結果的需求日益成長，即時檢測（POC​​）解決方案正受到廣泛關注。根據IMARC Group預測，日本即時診斷市場規模預計在2024年達到17億美元。能夠使用單一試劑盒檢測多種病原體的攜帶式多重檢測設備正變得越來越精密。這些進步有助於當日制定治療方案，並提高慢性病管理的效率。

2026-2034年市場展望：

攜帶式診斷設備的持續技術創新、遠端醫療的日益普及以及政府對數位健康計畫的支持將推動市場擴張。人口老化將維持對血糖監測和慢性病管理解決方案的需求，而年輕一代健康意識的提高將使消費群體更加多元化。預計2025年市場規模將達到3.5556億美元，到2034年將達到9.5629億美元，2026年至2034年的複合年成長率（CAGR）為11.62%。零售藥局的現代化和電子商務通路的拓展將提高都市區地區的產品供應量。

1. 日本的家庭診斷測試市場規模有多大？

2. 日本家庭診斷檢測市場的預期成長率是多少？

3. 在日本家庭診斷測試市場中，哪種類型的測試佔了最大的佔有率？

4.推動市場成長的關鍵因素是什麼？

5. 日本家庭診斷檢測市場面臨的主要挑戰是什麼？

目錄

第1章：序言

第2章：調查範圍與調查方法

  • 調查目標
  • 相關利益者
  • 數據來源
  • 市場估值
  • 調查方法

第3章執行摘要

第4章：日本家用診斷檢測市場概況

  • 概述
  • 市場動態
  • 產業趨勢
  • 競爭資訊

第5章：日本家用診斷檢測市場：現狀

  • 過去和當前的市場趨勢（2020-2025）
  • 市場預測（2026-2034）

第6章：日本家庭診斷檢測市場－依檢測類型細分

  • 血糖值監測儀
  • 妊娠測試
  • 排卵預測檢測套組
  • HIV檢測套組
  • 膽固醇檢測套裝
  • 傳染病檢查試劑盒
  • 藥物濫用檢測套組
  • 其他

第7章：日本家用診斷測試市場－按類型細分

  • 磁帶
  • 中游
  • 裝置
  • 條
  • 檢查
  • 數位監控
  • 沾卡

8. 日本家用診斷測試市場－依銷售管道分類

  • 零售藥房
  • 藥局
  • 大賣場和超級市場
  • 網路藥房

第9章：日本家庭診斷檢測市場（按地區分類）

  • 關東地區
  • 關西、近畿地區
  • 中部地區
  • 九州和沖繩地區
  • 東北部地區
  • 中國地區
  • 北海道地區
  • 四國地區

第10章：日本家庭診斷檢測市場：競爭格局

  • 概述
  • 市場結構
  • 市場公司定位
  • 關鍵成功策略
  • 競爭對手儀錶板
  • 企業估值象限

第11章主要企業概況

第12章：日本家用診斷檢測市場：產業分析

  • 促進因素、限制因素和機遇
  • 波特五力分析
  • 價值鏈分析

第13章附錄

簡介目錄
Product Code: SR112026A36397

The Japan home diagnostic testing market size was valued at USD 355.56 Million in 2025 and is projected to reach USD 956.29 Million by 2034, growing at a compound annual growth rate of 11.62% from 2026-2034.

The Japan home diagnostic testing market is experiencing robust expansion driven by the nation's rapidly aging population, which has led to increased prevalence of chronic conditions requiring frequent monitoring. Rising health awareness among consumers, coupled with preferences for convenient at-home testing solutions, continues to strengthen demand. Government initiatives promoting preventive healthcare and digital health integration further support market momentum. Technological advancements in portable diagnostic devices, combined with expanding retail pharmacy networks and growing e-commerce penetration, are enhancing product accessibility across the country, thereby bolstering Japan home diagnostic testing market share.

KEY TAKEAWAYS AND INSIGHTS :

  • By Test Type: Glucose monitoring devices dominate the market with a share of 34% in 2025, driven by Japan's rising diabetic population requiring regular blood sugar monitoring and the growing adoption of continuous glucose monitoring systems among elderly consumers seeking convenient disease management solutions.
  • By Form: Strips lead the market with a share of 29% in 2025, owing to their cost-effectiveness, ease of use for self-testing applications, and widespread availability across retail pharmacies and drug stores throughout Japan.
  • By Distribution Channel: Retail pharmacies represent the largest segment with a market share of 40% in 2025, supported by consumer trust in pharmacist guidance, extensive store networks offering comprehensive product assortments, and the convenience of immediate product availability for healthcare needs.
  • By Region: Kanto Region prevails the market with a share of 36% in 2025, attributable to its dense population concentration in metropolitan Tokyo, advanced healthcare infrastructure, high consumer spending power, and presence of major healthcare facilities and digital health startups.
  • Key Players: The Japan home diagnostic testing market exhibits a moderately competitive landscape, characterized by the presence of established multinational diagnostic corporations alongside domestic manufacturers offering diverse product portfolios across various testing categories and price segments.

The Japan home diagnostic testing market continues to benefit from the nation's commitment to healthcare innovations and the seamless integration of technology into daily health management routines. The MHLW's 8th National Medical Strategic Plan covering 2024-2029 emphasizes Information and Communications Technology (ICT) and digitalization in healthcare, creating favorable conditions for at-home diagnostic solutions. Consumer preference for privacy in health screening, particularly for sensitive conditions, further accelerates the demand for home-based testing alternatives that provide accurate results without clinical visits. Expanding retail availability, greater insurance support for preventive testing, and proactive government promotion of early detection also strengthen market prospects. As manufacturers introduce more user-friendly, reliable, and disease-specific test kits, the market is expected to diversify and accelerate, appealing to both older adults seeking independence and younger users looking for faster, more accessible health insights.

JAPAN HOME DIAGNOSTIC TESTING MARKET TRENDS:

Integration of Artificial Intelligence (AI) and Digital Health Technologies

The Japan home diagnostic testing market is witnessing significant transformation through AI integration into diagnostic devices and health platforms. Smart diagnostic equipment, featuring machine learning (ML) algorithms, enables continuous health monitoring and early detection of potential conditions. These technologies allow timely interventions while reducing dependence on frequent clinical visits. In January 2025, Monitor Corporation launched its AI lung cancer diagnosis tool, MONCAD CTLN, in Japan through a partnership with Doctor-NET, demonstrating the nation's commitment to advancing AI-powered diagnostic capabilities.

Rise of Telemedicine and Remote Patient Monitoring

The expansion of telemedicine services is creating synergies with home diagnostic testing solutions across Japan. Digital health platforms increasingly integrate with at-home testing kits, enabling seamless data sharing between patients and healthcare providers. This trend reflects growing consumer demand for convenient healthcare access and reduces burden on overcrowded healthcare facilities. In July 2024, Amazon introduced its Pharmacy service in Japan, partnering with various local drugstores to deliver prescription medicines directly to homes while enabling pharmacist consultations through digital applications.

Growing Adoption of Point-of-Care (POC) Testing Solutions

POC testing solutions are gaining substantial traction as consumers and healthcare providers seek immediate diagnostic results outside traditional laboratory settings. As per IMARC Group, the Japan POC diagnostics market size reached USD 1.7 Billion in 2024. Portable multiplex testing devices capable of detecting multiple pathogens in single cartridges are becoming increasingly sophisticated. These advancements support same-visit treatment decisions and enhance chronic disease management efficiency.

MARKET OUTLOOK 2026-2034:

Market expansion will be driven by continued technological innovation in portable diagnostic devices, expanding telemedicine adoption, and government support for digital health initiatives. The aging demographic will sustain demand for glucose monitoring and chronic disease management solutions, while growing health consciousness among younger population will diversify the consumer base. The market generated a revenue of USD 355.56 Million in 2025 and is projected to reach a revenue of USD 956.29 Million by 2034, growing at a compound annual growth rate of 11.62% from 2026-2034. Retail pharmacy modernization and e-commerce channel expansion will enhance product accessibility across urban and rural regions alike.

JAPAN HOME DIAGNOSTIC TESTING MARKET REPORT SEGMENTATION:

Test Type Insights:

  • Glucose Monitoring Devices
  • Pregnancy Test
  • Ovulation Predictor Test Kits
  • HIV Test Kits
  • Cholesterol Detection Kits
  • Infection Testing Kits
  • Drug of Abuse Test Kits
  • Others
  • Glucose monitoring devices dominate with a market share of 34% of the total Japan home diagnostic testing market in 2025.
  • Glucose monitoring devices hold prominence, as Japan's diabetes burden continues to escalate. In 2024, Japan had the 10th largest population of individuals with diabetes worldwide, totaling 10.8 Million. The elderly demographic demonstrates heightened susceptibility to type 2 diabetes and related metabolic conditions. Government reimbursement policies supporting diabetes management device accessibility further strengthen market penetration.
  • Self-monitoring blood glucose devices have become essential tools for daily disease management, enabling patients to track glucose fluctuations and adjust treatment regimens accordingly. This proactive approach helps prevent serious complications, including cardiovascular diseases and kidney disorders. The segment benefits from continuous technological innovations, enhancing device accuracy and user convenience. The integration of digital health applications with glucose monitors enables seamless data sharing with healthcare providers, facilitating personalized treatment adjustments and improving overall patient outcomes in chronic disease management.

Form Insights:

  • Cassettes
  • Midstream
  • Instruments
  • Strips
  • Test
  • Digital Monitoring
  • Dip Cards
  • Strips lead with a share of 29% of the total Japan home diagnostic testing market in 2025.
  • Strips represent the most accessible and cost-effective format for home diagnostic testing applications. Their simple operation requires minimal technical knowledge, making them suitable for elderly consumers and first-time users seeking reliable self-testing solutions. Blood sample collection using strips provides accurate results comparable to laboratory testing while offering the convenience of immediate readings at home. The format's versatility extends across multiple testing categories, including glucose monitoring, cholesterol detection, and infection screening applications.
  • Manufacturing advancements have significantly improved strip sensitivity and accuracy, building consumer confidence in home testing reliability. The format's affordability compared to electronic instruments supports regular testing frequency among chronic disease patients requiring daily monitoring. Retail pharmacies and drug stores maintain comprehensive strip inventories across major brands, ensuring consistent product availability. The established distribution infrastructure combined with competitive pricing strategies positions strips as the preferred format for budget-conscious consumers prioritizing testing accessibility over advanced digital features.

Distribution Channel Insights:

  • Retail Pharmacies
  • Drug Stores
  • Hypermarket and Supermarkets
  • Online Pharmacies
  • Retail pharmacies exhibit a clear dominance with a 40% share of the total Japan home diagnostic testing market in 2025.
  • Retail pharmacies serve as primary healthcare access points throughout Japan, offering consumers professional pharmacist consultation alongside diagnostic product purchases. As per IMARC Group, the Japan pharmacy retail market size reached USD 114.26 Billion in 2024. These establishments provide personalized guidance on product selection, proper testing procedures, and result interpretation, creating value-added shopping experiences that build consumer loyalty. Chain pharmacy dominance ensures standardized service quality and comprehensive product assortments across locations.
  • The channel benefits from established consumer trust in pharmacist expertise and healthcare-related purchasing environments. Immediate product availability eliminates waiting periods associated with online ordering, appealing to consumers requiring urgent diagnostic solutions. Strategic pharmacy locations in residential neighborhoods and commercial districts maximize accessibility for diverse demographic segments. Retail pharmacies increasingly integrate digital services, including prescription management and telemedicine consultations, positioning themselves as comprehensive health management hubs that complement home diagnostic testing product offerings.

Regional Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central/Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • Kanto Region represents the leading region with a 36% share of the total Japan home diagnostic testing market in 2025.
  • The Kanto Region leads the Japan home diagnostic testing market due to its large, urbanized population, advanced healthcare infrastructure, and strong digital adoption. Tokyo is a large urban city with approximately 37.1 Million inhabitants in 2024. Consumers in Tokyo and surrounding prefectures actively embrace convenient at-home testing solutions to save time and manage health proactively. High awareness about preventive care and broad access to pharmacies, clinics, and online platforms enable rapid market penetration and frequent product upgrades.
  • The region also benefits from the strong presence of technology companies and diagnostic manufacturers that introduce innovative, app-connected self-testing kits tailored to urban lifestyles. Widespread use of smartphones, telehealth platforms, and digital health records supports seamless integration of home diagnostic tools. Additionally, higher disposable incomes and busy work schedules create sustained demand for reliable, fast, and easy-to-use testing options, reinforcing Kanto's position as the most influential and early-adopting market in Japan.

MARKET DYNAMICS:

GROWTH DRIVERS:

  • Why is the Japan Home Diagnostic Testing Market Growing?
  • Rapidly Aging Population and Escalating Chronic Disease Burden
  • Japan's demographic transformation represents a fundamental driver propelling the home diagnostic testing market forward. The nation possesses one of the world's oldest populations, with individuals aged 65 and over comprising 29.3% of total residents as of September 2024. This substantial elderly cohort demonstrates elevated susceptibility to chronic conditions, including diabetes, cardiovascular diseases, and metabolic disorders requiring continuous monitoring. Home diagnostic devices enable convenient disease management without frequent clinical visits, particularly valuable for mobility-limited seniors. Home diagnostic tools provide a convenient, accessible, and non-invasive alternative that enables seniors to track vital health parameters from the comfort of their homes. This shift not only empowers individuals to take greater control of their health but also reduces pressure on overburdened hospitals and clinics, allowing medical professionals to focus on more severe cases.
  • Government Initiatives Supporting Digital Health and Home Healthcare
  • Japanese government policies actively promote home-based healthcare and digital health integration, creating favorable regulatory conditions for market participants. These initiatives encourage telemedicine adoption and remote patient monitoring capabilities that complement home diagnostic testing solutions. As per IMARC Group, the Japan telemedicine market size reached USD 5.2 Billion in 2024. Regulatory pathways have also become more supportive, simplifying approvals for innovative home testing devices and ensuring they meet safety standards. Initiatives encouraging collaborations between medical device manufacturers, tech companies, and healthcare providers further stimulate product innovation tailored to Japan's demographic needs. By reducing regulatory friction, improving digital accessibility, and promoting self-care, the government is effectively shifting health management from clinics to homes, making home diagnostic testing a central part of Japan's modern healthcare strategy.
  • Growing need for nursing care
  • The rising need for nursing care in Japan is strongly driving the home diagnostic testing market, as more individuals, particularly seniors, require continuous monitoring of chronic conditions without relying solely on in-person medical support. In fiscal 2023, in Japan, the overall number of nursing care recipients grew to 5,666,500, marking a 1.3% rise, while the total for preventive care recipients increased by 59,900 (5.1%) to reach 1,244,600. With the country facing a growing shortage of professional caregivers and nurses, families increasingly turn to home-based diagnostic tools to simplify daily health management. These devices allow routine checks for blood glucose, blood pressure, heart rhythm, and other vital indicators, reducing the burden on nursing staff while empowering patients to manage their conditions independently. Home diagnostic solutions also help caregivers track health status more efficiently, enabling early detection of complications and timely medical intervention. For elderly individuals living alone or in assisted environments, self-testing devices enhance safety and autonomy while minimizing frequent clinic visits.

MARKET RESTRAINTS:

  • What Challenges the Japan Home Diagnostic Testing Market is Facing?
  • Regulatory Complexity and Lengthy Approval Processes
  • Japan's stringent medical device regulations create substantial barriers for market entry and product innovations. Complex certification requirements extend approval timelines, delaying introduction of advanced diagnostic technologies. Manufacturers face significant compliance costs navigating regulatory pathways, particularly for novel AI-integrated devices requiring extensive clinical validation.
  • High Device Costs Limiting Consumer Accessibility
  • Premium pricing of advanced home diagnostic devices restricts market penetration among price-sensitive consumer segments. Sophisticated continuous glucose monitoring systems and connected health devices remain financially inaccessible for many households despite clinical benefits. Limited insurance coverage for certain diagnostic categories creates out-of-pocket burden that suppresses demand growth.
  • Data Privacy and Security Concerns
  • Data privacy and security concerns are slowing the growth of the market in Japan by reducing consumer confidence in sharing sensitive health information through digital platforms. Fears of data leaks, misuse of personal medical records, and inadequate protection measures make users hesitant to adopt app-connected or cloud-based test kits. These concerns also pressure companies to invest heavily in compliance, cybersecurity, and transparent data-handling practices, increasing operational complexity.

COMPETITIVE LANDSCAPE:

  • The Japan home diagnostic testing market exhibits moderate competitive intensity, characterized by the presence of established multinational medical device corporations alongside domestic manufacturers. Global players leverage advanced research capabilities, extensive distribution networks, and brand recognition to maintain market positions across premium product categories. Domestic companies compete through localized product development, competitive pricing strategies, and established relationships with healthcare providers and retail channels. Strategic partnerships between technology firms and diagnostic manufacturers are accelerating innovations in connected health solutions. Market participants are increasingly investing in AI integration, digital platform development, and user experience enhancement to differentiate offerings. Distribution channel expansion, particularly through e-commerce and pharmacy partnerships, represents a key competitive focus area.
  • KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the Japan home diagnostic testing market?

2. What is the projected growth rate of the Japan home diagnostic testing market?

3. Which test type held the largest Japan home diagnostic testing market share?

4. What are the key factors driving market growth?

5. What are the major challenges facing the Japan home diagnostic testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Home Diagnostic Testing Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Home Diagnostic Testing Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Home Diagnostic Testing Market - Breakup by Test Type

  • 6.1 Glucose Monitoring Devices
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Pregnancy Test
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 Ovulation Predictor Test Kits
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)
  • 6.4 HIV Test Kits
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2020-2025)
    • 6.4.3 Market Forecast (2026-2034)
  • 6.5 Cholesterol Detection Kits
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2020-2025)
    • 6.5.3 Market Forecast (2026-2034)
  • 6.6 Infection Testing Kits
    • 6.6.1 Overview
    • 6.6.2 Historical and Current Market Trends (2020-2025)
    • 6.6.3 Market Forecast (2026-2034)
  • 6.7 Drug of Abuse Test Kits
    • 6.7.1 Overview
    • 6.7.2 Historical and Current Market Trends (2020-2025)
    • 6.7.3 Market Forecast (2026-2034)
  • 6.8 Others
    • 6.8.1 Historical and Current Market Trends (2020-2025)
    • 6.8.2 Market Forecast (2026-2034)

7 Japan Home Diagnostic Testing Market - Breakup by Form

  • 7.1 Cassettes
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Midstream
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Instruments
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)
  • 7.4 Strips
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2020-2025)
    • 7.4.3 Market Forecast (2026-2034)
  • 7.5 Test
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2020-2025)
    • 7.5.3 Market Forecast (2026-2034)
  • 7.6 Digital Monitoring
    • 7.6.1 Overview
    • 7.6.2 Historical and Current Market Trends (2020-2025)
    • 7.6.3 Market Forecast (2026-2034)
  • 7.7 Dip Cards
    • 7.7.1 Overview
    • 7.7.2 Historical and Current Market Trends (2020-2025)
    • 7.7.3 Market Forecast (2026-2034)

8 Japan Home Diagnostic Testing Market - Breakup by Distribution Channel

  • 8.1 Retail Pharmacies
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Drug Stores
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)
  • 8.3 Hypermarket and Supermarkets
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Forecast (2026-2034)
  • 8.4 Online Pharmacies
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2020-2025)
    • 8.4.3 Market Forecast (2026-2034)

9 Japan Home Diagnostic Testing Market - Breakup by Region

  • 9.1 Kanto Region
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Breakup by Test Type
    • 9.1.4 Market Breakup by Form
    • 9.1.5 Market Breakup by Distribution Channel
    • 9.1.6 Key Players
    • 9.1.7 Market Forecast (2026-2034)
  • 9.2 Kansai/Kinki Region
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Breakup by Test Type
    • 9.2.4 Market Breakup by Form
    • 9.2.5 Market Breakup by Distribution Channel
    • 9.2.6 Key Players
    • 9.2.7 Market Forecast (2026-2034)
  • 9.3 Central/ Chubu Region
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2020-2025)
    • 9.3.3 Market Breakup by Test Type
    • 9.3.4 Market Breakup by Form
    • 9.3.5 Market Breakup by Distribution Channel
    • 9.3.6 Key Players
    • 9.3.7 Market Forecast (2026-2034)
  • 9.4 Kyushu-Okinawa Region
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2020-2025)
    • 9.4.3 Market Breakup by Test Type
    • 9.4.4 Market Breakup by Form
    • 9.4.5 Market Breakup by Distribution Channel
    • 9.4.6 Key Players
    • 9.4.7 Market Forecast (2026-2034)
  • 9.5 Tohoku Region
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2020-2025)
    • 9.5.3 Market Breakup by Test Type
    • 9.5.4 Market Breakup by Form
    • 9.5.5 Market Breakup by Distribution Channel
    • 9.5.6 Key Players
    • 9.5.7 Market Forecast (2026-2034)
  • 9.6 Chugoku Region
    • 9.6.1 Overview
    • 9.6.2 Historical and Current Market Trends (2020-2025)
    • 9.6.3 Market Breakup by Test Type
    • 9.6.4 Market Breakup by Form
    • 9.6.5 Market Breakup by Distribution Channel
    • 9.6.6 Key Players
    • 9.6.7 Market Forecast (2026-2034)
  • 9.7 Hokkaido Region
    • 9.7.1 Overview
    • 9.7.2 Historical and Current Market Trends (2020-2025)
    • 9.7.3 Market Breakup by Test Type
    • 9.7.4 Market Breakup by Form
    • 9.7.5 Market Breakup by Distribution Channel
    • 9.7.6 Key Players
    • 9.7.7 Market Forecast (2026-2034)
  • 9.8 Shikoku Region
    • 9.8.1 Overview
    • 9.8.2 Historical and Current Market Trends (2020-2025)
    • 9.8.3 Market Breakup by Test Type
    • 9.8.4 Market Breakup by Form
    • 9.8.5 Market Breakup by Distribution Channel
    • 9.8.6 Key Players
    • 9.8.7 Market Forecast (2026-2034)

10 Japan Home Diagnostic Testing Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Products Offered
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Products Offered
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Products Offered
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Products Offered
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Products Offered
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan Home Diagnostic Testing Market - Industry Analysis

  • 12.1 Drivers, Restraints, and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix